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Abstract
The risk of suicidal behaviour in mood disorders is an inherent phenomenon 
and in patients with major mood disorders it strongly relates to the presence 
and severity of depressive episode. Suicidal behaviour in patients with mood 
disorders is state and severity dependent that means that suicidality markedly 
decreases or vanishes after clinical recovery. However, since the majority of 
mood disorder patients never commit and more than half of them never at-
tempt suicide, special clinical characteristics of the illness as well as some 
personality, familial and psycho-social factors should also play a contributory 
role. Considering the clinically explorable suicide risk factors in patients with 
major mood disorders (family and/or personal hisotry of suicidal behaviour, 
early onset of mood disorder, severe depressive episode/hopelessness, agitat-
ed/mixed depression, bipolar I or II diagnosis, rapid cycling course, comorbid 
Axis I and Axis II disorders, adverse life situations, lack of social and medical 
support, cyclothymic temperament, impulsive aggressive personality features, 
etc.), suicidal behaviour is predictable with a good chance. Successful acute 
and long-term pharmacotherapy markedly reduces the risk of attempted and 
completed suicide, even in this high-risk population. Supplementary psycho-
social interventions (psychoeducation and targeted psychotherapies) further 
improve the results.
Keywords: Major depressive disorder, bipolar disorders, suicidal behaviour, 
suicide risk factors, pharmacotherapy, psychosocial interventions
Introduction
Suicidality is one of the most alarming signs in psychiatry and it is the 
most hard end-point and most visible treatment outcome in patients with 
psychiatric disorders. Suicidal behaviour is very complex, multi-causal 
behaviour, involving several medical-biologic, psychosocial and cultural 
components, and history of untreated major mood disorders (particu-
larly in the presence of previous suicide attempt) is the most important 
risk factor. However, because the majority of mood disorder patients 
never complete (and around 50% of them never attempt) suicide, other 
familial-genetic, personality, psychosocial and demographic risk factors 
should also play a significant contributory role 1-4.
Psychological autopsy studies from different parts of the world consis-
tently show that around 90% of consecutive suicide victims have one or 
more Axis I (mostly untreated) major psychiatric disorders at the time of 
their death, and major mood disorders (59-87%) schizophrenia/schizoaf-
fective disorder (10-12%) and substance-use disorders (10-15%) are the 
most common principal diagnoses. Comorbid anxiety and personality 
disorders are also frequently present, but they are rare as principal (or 
only) diagnoses 1 3-5. It has been estimated that 15-19% of severe (mostly 
hospitalized) patients with major depression would die by suicide 6. In 
their meta-analysis of studies on suicide risk in psychiatric disorders, 
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Harris and Barraclough 7 analysed separately the risk 
of suicide in unipolar major depression and in bipo-
lar disorder. They found that the risk of suicide was 
about 20-fold for patients with index diagnosis of uni-
polar major depression, and the same figure for bipo-
lar disorder was 15. However, these studies 6 7 cannot 
provide a precise estimation of separate suicide risk 
in unipolar and bipolar disorder, i.e. they overestimate 
the risk for unipolar depression and underestimate it 
for bipolar disorders. The main sources of these are 
that the index diagnosis frequently change during the 
long-term course from unipolar depression to bipolar I 
or bipolar II disorder 8-11 and in the studies (performed 
several decades ago) reviewed by the mentioned 
authors the diagnostic category of bipolar II depres-
sion (depression with hypomania but without mania) 
which is quite common form of bipolar disorders 9 12 
has not been considered separately and it is very 
likely that the majority of bipolar II patients in these 
studies were included in the unipolar major depres-
sive subgroup. Indeed, a recent long-term follow-up 
study showed that the rate of completed suicide was 
about double in bipolar disorder (types I and II com-
bined) than in unipolar depression 13. Another three 
recent population based epidemiological studies also 
found a substantially higher rate of suicide attempts 
in bipolar (types I and II combined) than in unipolar 
major depressive disorder patients 14-16.
Risk of suicidal behavior in patients  
with unipolar major depression or bipolar 
disorders
Completed suicide
The different suicide risk in the three main subgroups of 
major mood disorders has been first reported by Dun-
ner et al. 17 who found that 3% of the 73 unipolar, 6% 
of the 68 bipolar I and 18% of the 22 bipolar II patients 
died by suicide during their 1-9 year follow-up study. In 
contrast to this, in a 40 to 44 years’ prospective follow-
up study of 406 formerly hospitalised (186 unipolar and 
220 bipolar) major mood disorder patients, in which the 
unipolar-bipolar conversion was carefully considered 
during the follow-up, Angst et al. 18 found that 14.5% of 
unipolar and 8.2% of bipolar (I + II) patients completed 
suicide; the SMRs for suicide in unipolar and bipolar 
patients were 26 and 12, respectively.
In their recent long-term prospective follow up study 
(average 11 years) on 1983 unipolar major depres-
sives and 843 bipolar (I + II) patients, Tondo et al. 19 
found five-times fold higher rate of completed suicide 
in bipolar I and II than in unipolar patients (0.25% of 
patients/year vs. 0.05% of patients/year). This study 
also found that the ratio of attempted to completed sui-
cide in bipolar II, bipolar I and unipolar depression was 
5, 11, and 10, respectively, showing that the lethality of 
suicide attempts was far highest in bipolar II patients. 
The higher risk of suicide of bipolar II than bipolar I 
and unipolar patients has been also supported by the 
study of Sani et al. 16. During this long-term (up to 35 
years) follow-up study on 4441 formerly hospitalized 
psychiatric patients it has been also found that bipolar 
II patients had the highest risk for suicide; 2.8% of 1163 
bipolar I and 4.2% of 602 bipolar II patients completed 
suicide while the same rate of 1142 unipolar major de-
pressive patients was 1.9% 13. Similarly, in the STEP-
BD study (4360, mostly pharmacologically treated bi-
polar patients; mean follow-up period was 16 months) 
the rate of completed suicide was more than two-fold 
higher in bipolar II (0.34%) than in bipolar I patients 
(0.14%) 20. Investigating the risk of completed suicide 
in a total Danish national cohort of patients with first 
psychiatric discharge (n = 176.347) Nordentoft et al. 21 
found that the lifetime risk for suicide in bipolar disor-
ders were 7.8% for males and 4.8% for females, while 
the same figures for patients with unipolar depression 
were 6.7% and 3.8%, respectively.
Two psychological autopsy studies where the preva-
lence of bipolar II, bipolar I and unipolar depression 
have been analysed separately show that among the 
125 consecutive suicide victims with primary major 
depression at the time of suicide 44% had bipolar II 
depression, 2% had bipolar I depression and 54% had 
first episode or recurrent unipolar depression  22  23. 
Because the lifetime prevalence rates of DSM-III/IV-
defined bipolar illness in the population are relatively 
low compared with unipolar major depression (2-5% 
and 15-17%, respectively) 24-26, these results – in 
agreement with other findings 13 20 – also suggest that 
among different subgroups of major mood disorders 
the bipolar – particularly bipolar II – types carry the 
highest risk of completed suicide.
Suicide attempts
Up to fifty percent of patients with major mood disor-
ders have at least one suicide attempt during their life-
time 2 4 15. Considering only the ten studies, in which 
unipolar, bipolar I and bipolar II patients were analysed 
separately, the rate of previous suicide attempts is the 
lowest in unipolar major depression (13 %) highest in 
bipolar II patients (33%), and intermediate in bipolar 
I patients (28%) 2. Re-analysing the ECA database, 
Judd and Akiskal 27 also reported that the rate of prior 
suicide attempt(s) was higher in bipolar II (34%) than 
suicidal behaviour in patients with mood disorders
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in bipolar I (24%) patients, while the same figure for 
unipolar major depression was only 16% 28. Similarly, 
a study from Norway on 201 major mood disorder pa-
tients found that the lifetime history of suicide attempts 
in bipolar II, bipolar I and unipolar depressives were 
61%, 50%, and 30%, respectively 29.
A German ten-year prospective longitudinal study 
showed that 32% of 33 bipolar II, 17% of 65 bipolar 
I and 6% of 286 pure unipolar major depressive pa-
tients attempted suicide during the follow-up 14. In the 
Finnish Jorvi Bipolar Study 16% of the 90 bipolar I 
and 25% of the 101 bipolar II patients have reported 
at least one prior suicide attempt at the index epi-
sode  30. Similar findings were reported from South-
Korea; 17% of the 71 bipolar I and 36% of the 34 
bipolar II patients reported the history of suicide at-
tempt 31. Looking at the different diagnostic subtypes 
of consecutive suicide attempters with current DSM-
IV major depressive episode, it has been also found 
that bipolar, and particularly bipolar II patients were 
relatively overrepresented among them both in Buda-
pest, Hungary and in Rome, Italy 32 33.
The long-term prospective study by Tondo et al. 19 
found that the annual rate of suicide attempts during 
the follow-up was more than double in bipolar (I + II) 
than in unipolar patients and it was higher in bipolar 
I (1.52%), than in bipolar II (0.82%) and in unipolar 
(0.48%) depression. In a most recent population-
based study on 935 bipolar I and 494 bipolar II pa-
tients Bega et al. 34 reported that lifetime suicide at-
tempts were more common in bipolar I patients: 29% 
of bipolar I and 15 % of bipolar II patients reported past 
suicide attempt. Similarly, in the STEP-BD study 4,6% 
of bipolar I and 3% of bipolar II patients have made 
suicide attempt during the 18 month follow-up 20.
The role of mixed (bipolar) depression in suicidal 
behaviour
The majority of the studies shows that officially diag-
nosed DSM-IV bipolar disorders carry much higher 
risk of suicidal behaviour than unipolar major de-
pressive disorder indicating that the bipolar compo-
nent of major mood disorders could be one of the 
responsible factors. Therefore it is not surprising that 
subthreshold intradepressive (hypo)manic symptoms 
during DSM-IV unipolar major depressive disorder 
(mixed depression) also increase the risk of suicidal 
behaviour. It is important to note that mixed depres-
sive episode (depression plus 3 or more co-occurring 
intradepressive hypomanic symptoms) and agitated 
depression are greatly overlapping conditions 35 36.
Analysing the NCS-Replication database Angst et 
al. 15 also reported that the history of lifetime suicide 
attempts was the highest in bipolar I (66%), lower in 
bipolar II disorder (50%) and lowest in unipolar ma-
jor depression without subthreshold bipolarity (30%). 
However, in patients with unipolar major depression 
with lifetime or current (intradepressive) subthreshold 
(hyp)omanic symptoms, the rate of patients with prior 
suicide attempt was intermediate between pure uni-
polar major depression and bipolar II disorder (41%). 
Similar findings have been reported by Jabben et al. 37: 
the lifetime history of suicide attempts in bipolar I, bi-
polar II and unipolar depression were 37%, 21%, and 
18%, respectively, but the same rate in unipolar major 
depressives with subthreshold hypomanic symptoms 
was 38%. The importance of subthreshold bipolarity 
in patients with major depressive episode in suicidal 
behaviour is further underscored by the findings that 
those bipolar I or II depressives with some clinically 
significant intradepressive (hypo)manic symptoms 
showed significantly more suicide attempts at the in-
dex episode and during the long-term follow-up (54% 
and 58%, respectively) than those with no clinically 
significant (hypo)manic symptoms (32% and 35%, 
respectively) 38. Investigating 87 young adults with 
DSM-IV diagnosed major depressive episode it was 
also found that 36% of bipolar depressives (types I 
and II combined) and 15% of pure unipolar depres-
sives have made at least one prior suicide attempt, 
and the same rate in unipolar depressive patients 
with subthreshold (hypo)manic symptoms was 25% 
39. The elevated risk of suicidality in bipolar and bipo-
lar spectrum patients could be the result of a complex 
interaction of several clinical factors, as threshold and 
subthreshold bipolar patients are most often mixed/
agitated, show frequently rapid cycling course, pre-
dominant depressive polarity and they show a higher 
rate of anxiety and substance-use comorbidity.
Clinically detectable suicide risk factors 
in patients with major mood disorders
Specific clinical and personality characteristics
Major mood disorder patients with early onset of the 
illness, hopelessness, insomnia as well as with co-
morbid anxiety, substance-use and personality dis-
orders are also at an increased risk of attempted 
or completed suicide 2-4 28 32 40-43. Beside the highest 
lethality of suicide attempts 13 19, the major causes 
of the highest suicide risk in bipolar patients may 
be the high rate of comorbid anxiety disorders 42 44, 
substance-use disorders 4 45 and depressive mixed 
states/agitated depression 9 13 36 38 46-48.
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Impulsivity as a personality trait increase suicide risk 
when combined with depression and even modest 
manic symptoms during bipolar depressive episodes 
are associated with greater level of impulsivity and 
higher rate of suicide attempts 49-51. Current findings 
also show that in contrast to hyperthymic tempera-
ment cyclothymic/irritable/depressive affective tem-
peraments, that are characteristic also for bipolar 
(mainly for bipolar II) disorder also increase the risk 
of suicidal behaviour in patients with bipolar and uni-
polar major depressive episode 52-54.
Personal and family history of suicide
Family history of suicide among first and second de-
gree relatives 17 55 56 and past suicide attempt(s) 2 3-5 57 
have been also shown as powerful risk factors for at-
tempted or completed suicide, particularly during ma-
jor depressive, mixed depressive or dysphoric manic 
episodes. Bipolar and unipolar patients with family 
history of suicidal behavior and exposed to childhood 
physical and/or sexual abuse are at greater risk for 
suicide attempts 51 57. Impulsivity seems to be the link 
between childhood abuse and suicidal behavior par-
ticularly in the case of major depressive episode 58. A 
study on 211 patients suffering from recurrent unipo-
lar major depression or bipolar (I-II) disorder, hospi-
talized after suicide attempt, it was found that family 
history of suicide was significantly associated with 
the diagnosis of bipolar disorder and looking for the 
features associated with serious suicide attempt, bi-
polar disorder was the only associated diagnosis 59.
Adverse life events
Adverse life events play important role in suicidal pro-
cess as predisposing (childhood events, including 
physical and sexual abuse) and precipitating (adult-
hood events) factors 51. Although negative life events 
do not lead inevitably to suicidal behavior in healthy 
persons or even in the high-risk groups such as psy-
chiatric (particularly mood disorder) patients, but they 
may actually trigger the suicidal process 1 60 61. Over 
40 percent of patients with bipolar disorder report a 
history of childhood physical and/or sexual abuse and 
depressed patients with such a history have earlier 
age of onset of bipolar illness, greater psychiatric co-
morbidity and increased rates of suicide attempts 43 57.
About half of all completed suicides in both bipolar I 
and unipolar mood disorders are associated with re-
cent negative life events, but the stressors are com-
monly dependent on the victims’s own behaviour, par-
ticularly in the case of bipolar I disorder 60. Hypomanic 
and particularly manic episodes can easily lead to ag-
gressive-impulsive behavior, financial extravagance, 
or episodic promiscuity, thus generating several inter-
personal conflicts, marital breakdown and new nega-
tive life events, all of which have a negative impact on 
the further course of the illness which may ultimately 
trigger suicidal behavior. Permanent adverse life situ-
ations (e.g., unemployment, social isolation) as well 
as acute psychosocial stressors (e.g., loss events, fi-
nancial breakdowns) in adult patients with unipolar or 
bipolar disorders are useful indicators of suicidality in 
the clinical practice, primarily if other risk factors are 
also present 60-63. In the majority of cases more than 
one suicide risk factor are present simultaneously and 
their effect is cumulative: the higher is the number of 
risk factors the higher is the suicide risk  2-4 64. More 
than one-third of suicide victims have made at least 
one prior suicide attempt which indicates that the ma-
jority of suicide victims die by their first attempt 1 3 and 
since most of them have a (mainly untreated) current 
major depressive episode, it is very important to de-
tect suicide risk as early as possible, particularly in 
depressed patients, and intervene even prior to the 
subject making his/her first suicide act.
Suicide protective factors in major mood 
disorder
In contrast to numerous suicide risk factors, only a 
few circumstances are known to have a protective ef-
fect. Good family and social support, pregnancy and 
postpartum period, having a great number of children, 
holding strong religious beliefs, and restricting lethal 
suicide methods (e.g., to reduce domestic and car 
exhaust gas toxicity and to introduce stricter laws on 
gun control) whenever possible, seem to have some 
protective effect 65-67. Recent studies have found that 
hyperthymic temperament may be also a protective 
factor 52 53 68 69. However, one of the most extensively 
studied and changeable suicide protective factor in 
major mood disorders is the acute and long-term 
pharmacological treatment 4 18 43 70 71.
Medical contact before suicidal events
Despite of the fact that up to 66% of suicide victims 
contact different levels of health care (mostly GPs and 
psychiatrists) during the 4-week period before their 
suicide, the rate of adequate pharmacotherapy among 
depressed suicide victims is disturbingly low 1 22 72 73. 
While the current prevalence of DSM-III/DSM-IV or 
ICD-10 major depression in the primary care practice 
is around 8-10%, the majority of depressed patients 
suicidal behaviour in patients with mood disorders
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are not recognised by their GPs. Moreover, the rate 
of adequate antidepressive pharmacotherapy among 
diagnosed depressives was less than 20%. However, 
studies performed 5-10 years later, reported much 
higher rates of recognition and treatment of depres-
sion in primary care practice (62-85%) and 33-50% of 
them were treated with antidepressants 69 74.
Since successful acute and long-term pharmaco-
therapy of mood disorders relieves not only the clini-
cal symptoms, but parallel with this also decreases 
or vanishes suicidality, the appropriate treatment 
of mood disorders is a key issue in suicide preven-
tion 3 4 23 43 69 71 72 75 76. 
Table I shows the clinically most important suicide 
risk factors in patients with major mood disorders.
The role of underlying bipolarity  
in antidepressant-resistance  
and antidepressant-associated suicidal 
behaviour
One of the most common sources of antidepressant-
resistance is the unrecognized bipolar nature of the 
“unipolar” major depressive episode 71 77-79. Unrecog-
nized bipolar depressives (mainly bipolar II depres-
sives in the daily clinical practice) and mixed “unipo-
lar” depressed patients with intradepressive (hypo)
manic symptoms in the randomized controlled trials 
on unipolar major depression are considered as “uni-
polar” major depressives that means that these pa-
tients receive antidepressants and co-administered 
anxiolytics but not mood stabilizers 14 15. This can re-
sult in a high rate of treatment resistance, which is 
about two-times higher in patient groups mentioned 
above compared to patients with true unipolar ma-
jor depression. In open clinical studies the frequency 
of antidepressant-resistance ranges from 41-65% in 
bipolar (types I and II combined) depression and be-
tween 18-27% in unipolar depression 71 77 78. Another 
study have shown that 80% of AD-resistant “unipolar” 
depressives have threshold or subthreshold bipolar 
disorder 80. In addition, it has been found that the 
rate of the bipolar spectrum disorder among the 212 
DSM-IV defined antidepressant responsive unipolar 
major depressive disorder inpatients was 3.8% but 
the same figure in 68 antidepressant-resistant inpa-
tients was 47.1% indicating that the underlying bipolar 
diathesis was important contributor to antidepressant 
nonresponse. Similarly, a significantly higher rate of 
antidepressant nonresponse in „pre-bipolar” major 
depressives than in pure major depressives have 
been also reported by Li et al. 79.
Moreover, antidepressant monotherapy – without the 
coadministration of mood stabilizers or atypical anti-
psychotics – in bipolar and bipolar spectrum depres-
sive subjects can worsen the cross-sectional picture 
of depression (particularly in adolescents and young 
adults) not only by causing (hypo)manic switch, but 
also via inducing or aggravating depressive mixed 
state/agitation, that is the major substrate of suicidal 
behaviour 9 47 70 71 78 81. The retrospective chart-review 
of 17 patients with “pre-bipolar” major depression 
(i.e., patients who become bipolar I and II during the 
follow-up) and of another 17 patients with pure unipo-
lar depression showed that family history of complet-
ed suicide and bipolar disorder, early onset of major 
depressive episode as well as treatment-emergent 
mixed depression, mood lability, psychomotor activa-
tion, suicidality and non-response to antidepressant 
monotherapy were significantly more common in “pre-
bipolar” than in pure unipolar depressives 78. Initial 
antidepressant monotherapy of patients subsequently 
diagnosed as bipolar disorder may result in higher 
switch rate and more frequent suicidal behaviour 81.
However, recent results show that a significant part 
(30-40%) of DSM-IV diagnosed unipolar major de-
Table I. Clinically detectable suicide risk factors in pa-
tients with mood disorders.
•	 Diagnostic subtype: Bipolar II = Bipolar I > Unipolar
•	 Early onset of the illness (< 25 years)
•	 Previous/current suicidal ideation
•	 Previous suicide attempt
•	 Current clinical features:
 - Severe depression, hopelessness, insomnia, guilt;
 - Mixed depressive episode/agitatated depression;
 - Dysphoric (mixed) mania or hypomania;
 - Mixed affective episode;
 - Rapid cycling course;
 - First episode depression, predominantly depres-
sive polarity;
 - Comorbid anxiety/anxiety disorders, substance-
use and personality disorders;
 - Cyclothymic/irritable/depressive affective tempera-
ments;
 - Impulsive/aggressive personality features
•	 Family history of suicide in first- and second degree 
relatives
•	 History of childhood physical and/or sexual abuse
•	 Permanent adverse life situations, acute psychoso-
cial stressors
•	 Lacking adequate acute and/or long-term treatment/
care
•	 Noncompliance with the acute and/or long-term treat-
ment
Z. Rihmer et al.
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pressive disorder patients have clinically significant 
lifetime or current subthreshold (hypo)manic symp-
toms (mixed depression), as well as other basic clini-
cal features (family history of bipolar disorder, early 
onset, bipolar conversion, etc.) that are characteristic 
and external validators for bipolar disorder 14 15 35 82. 
This means that more than one-third of DSM-IV diag-
nosed unipolar depressives are in fact subthreshold 
bipolar depressives and beside the antidepressant 
resistance primarily these patients are the subjects 
of bipolar conversion 14 82. The slightly elevated (but 
in absolute sense quite low) risk of suicidal behaviour 
among patients taking antidepressants compared to 
those taking placebo in randomised controlled anti-
depressant trials on DSM-IV diagnosed unipolar ma-
jor depressive disorder might be the consequence of 
the depression-worsening potential of antidepressant 
monotherapy in subthreshold and mixed bipolar de-
pressed patients who were included into these trials 
falsely diagnosed as suffering from unipolar depres-
sion 70 71 76. Antidepressants can worsen depression 
but it is not the case for placebo and worsening of 
depression is the “final cause” of suicidal behaviour 
even in drug-free patients. In other words, when anti-
depressants worsen depression in a few patients, its 
psychopathological substrate might well reside in an 
agitated, excited, mentally overstimulated, anxious 
(bipolar) depressive mixed state 9 70 71.
Successful acute and long-term treatment of unipo-
lar major depression and bipolar disorders markedly 
reduces the suicide morbidity and mortality even in 
this high-risk population but – as mentioned above 
– antidepressants can worsen depression and can 
lead to suicidal behavior in a small vulnerable sub-
population 18 43 70 76. However, in the everyday clinical 
practice, the suicide preventive effect of antidepres-
sants highly overshadows this unwanted iatrogeny. 
As the consequence of the FDA Black Box Warning 
(BBW) in 2004, the recently decreased use of antide-
pressants in children and adolescents seen in some 
countries has been accompanied by a concurrent 
increase in suicide rates in that age-groups while 
in middle-aged and old persons, where the utiliza-
tion of antidepressants increased continuously the 
suicide rates decreased. These findings provided 
further support that the BBW, contrary to its inten-
tion, resulted in the increasing number of untreated 
young depressives and – ultimately – the markedly 
increased suicide mortality of this age group. This 
increase occured among young persons without an-
tidepressant treatment 83 84. The formal recognition 
of depressive mixed states in our official diagnostic 
system (a mixed features specifier across all mood 
syndromes in the DSM-V) will help to mark out those 
pseudo-unipolar mixed depressives for whom mood 
stabilizer and/or atypical antipsychotic is the appro-
priate treatment (at the same time antidepressant 
monotherapy is contraindicated for these patients).
Suicide prevention in mood disorders 
– Pharmacological and psychosocial 
treatments
As suicidal behavior in unipolar and bipolar patients 
occur mostly during severe pure or mixed depressive 
episodes and less frequently in the frame of dys-
phoric (mixed) mania, but practically never during eu-
phoric mania and euthymia 2 3 43 47, it is not surprising 
that effective acute and long-term treatment of mood 
disorders have a strong protective effect against sui-
cidal behaviour 18 76 and probably against other com-
plications such as secondary substance-use disor-
ders, marital instability, loss of job, cardiovascular 
morbidity/mortality, violent behaviour, etc.
Recently, effective psychosocial interventions in the 
field of mood disorders were developed primarily for 
patients who show insufficient response to acute 
and long-term pharmacotherapy, who cannot toler-
ate drugs or who are noncompliant with the treat-
ment 85 86. The interaction between pharmacotherapy 
and psychosocial interventions is quite complex as 
successful episode-preventive medication counter-
acts dysfunctional cognitions (including low self-es-
teem) and adjunctive cognitive therapy helps to opti-
mize the long-term course 87.
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